Fineberg, S.E. (1999). The treatment of hypertension and dyslipidemia in diabetes mellitus. Primary Care 26(4): 951–964.
Parmley, W. (2001). How many medicines do patients with heart failure need?. Circulation 103(12):1611.
Cohn, J.N., Goldstein, S.O., Greenberg B.H., Lorell B.H., Bourge, R.C., Jaski, B.E., et al. (1998). A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. N. Engl. J. Med. 339(25):1810–1816.
French, A.R., Mason, T., Nelson, A.M., O’Fallon, W.M., and Gabriel, S.E. (2001). Increased mortality in adults with a history of juvenile rheumatoid arthritis: a population-based study. Arthritis Rheum. 44(3):523–527.
Strain, J.J., Caliendo, G., Alexis, J.D., Lowe, R.S., Karim, A., and Loigman, M. (1999). Cardiac drug and psychotropic drug interactions: significance and recommendations. Gen. Hosp. Psychiatry 21(6):408–429.
Lindquist, M., Stahl, M., Bate, A., Edwards, I.R., and Meyboom, R.H. (2000). A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database. Drug Safety 23(6):533–542.
Willenheimer, R. and Swedberg, K. (2000). Dressing heart-failure patients on Savile Row-tailored treatment. Lancet 355:2012–2013.
Holmes, J.H., Durbin, D.R., and Winston, F.K. (2000). Discovery of predictive models in an injury surveillance database: an application of data mining in clinical research. Proceedings of the AMIA Annual Symposium, pp. 359–363.
Downs, S.M. and Wallace, M.Y. (2000). Mining association rules from a pediatric primary care decision support system. Proceedings of the AMIA Annual Symposium 2000, pp. 200–204.
Bate A, Lindquist, M., Edwards, I.R., Olsson S., Orre, R., Lasner, A., et al. (1998). A Bayesian neural network method for adverse drug reaction signal generation. Eur. J. Clin. Pharmacol. 54:315–321.